Swiss National Bank Cyma Bay Therapeutics, Inc. Transaction History

Swiss National Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$12.63 - $24.47 $329,643 - $638,667	-26,100 Reduced 14.38%	155,400 $3.67 Million
Q3 2023 Nov 08, 2023	BUY	$10.86 - $17.62 $245,436 - $398,212	22,600 Added 14.22%	181,500 $2.71 Million
Q2 2023 Aug 09, 2023	SELL	$7.47 - $10.95 $177,786 - $260,609	-23,800 Reduced 13.03%	158,900 $1.74 Million
Q1 2023 May 10, 2023	BUY	$5.88 - $9.59 $1.07 Million - $1.75 Million	182,700 New	182,700 $1.59 Million
Q2 2021 Aug 06, 2021	SELL	$3.94 - $4.92 $429,460 - $536,280	-109,000 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$5.73 - $9.03 $624,570 - $984,269	109,000 New	109,000 $626,000
Q2 2020 Aug 05, 2020	SELL	$1.41 - $4.25 $166,944 - $503,200	-118,400 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$1.33 - $5.93 $3,325 - $14,825	2,500 Added 2.16%	118,400 $232,000
Q3 2019 Nov 12, 2019	BUY	$5.12 - $7.21 $15,360 - $21,630	3,000 Added 2.66%	115,900 $593,000
Q2 2019 Aug 02, 2019	BUY	$6.05 - $13.66 $13,915 - $31,418	2,300 Added 2.08%	112,900 $808,000
Q1 2019 May 10, 2019	BUY	$8.16 - $13.42 $93,024 - $152,988	11,400 Added 11.49%	110,600 $1.47 Million
Q4 2018 Feb 13, 2019	BUY	$6.54 - $11.74 $16,350 - $29,350	2,500 Added 2.59%	99,200 $781,000
Q2 2018 Aug 09, 2018	BUY	$10.66 - $14.38 $1.03 Million - $1.39 Million	96,700 New	96,700 $1.3 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.